跳至主要内容
临床试验/NCT02480972
NCT02480972已完成不适用

Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance Imaging (MRI)

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2015年6月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
69
试验地点
1
主要终点
difference of portal flow between no or early hepatic fibrosis and advanced hepatic fibrosis

研究概览

简要总结

The purpose of this study is to assess degree of hepatic fibrosis using multiparametric MRI for investigating difference between normal or early fibrosis and advanced fibrosis.

详细描述

In patients with liver parenchymal disease or normal liver parenchyma who are scheduled to undergo either liver resection or liver biopsy are included.

Referred patients undergo multiparametric MRI including perfusion, diffusion, elastography and fat quantification before surgery or biopsy.

The pathophysiologic changes are evaluated using multiparametric MRI, and compared between normal/early fibrosis and advanced fibrosis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients who are scheduled to undergo liver resection for focal liver lesion
  • patients who are scheduled to undergo liver resection or percutaneous biopsy for diffuse parenchymal disease
  • liver donor candidate who are scheduled to undergo preoperative liver biopsy or liver resection
  • AND patients/living donor candidates who sign informed consent

排除标准

  • Patients who have at least one of followings are excluded.
  • Patients who are contraindication for MRI contrast enhanced MRI.
  • Premenopausal female patients who are pregnant.
  • Patients who are physically compromised to acquire liver MRI

结局指标

主要结局

difference of portal flow between no or early hepatic fibrosis and advanced hepatic fibrosis

时间窗: in three years

次要结局

  • difference of arterial flow between no or early hepatic fibrosis and advanced hepatic fibrosis(in three years)
  • difference of liver stiffness value between no or early hepatic fibrosis and advanced fibrosis(in three years)
  • monitoring of transient dyspnea after contrast media injection(in three years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeong Min Lee

Professor

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验